Ro vs Fridays: Telehealth Scale vs a Focused Weight Program

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This PlexusDx Education Hub review weighs a large, established telehealth platform against a specialized weight program and what that gap means for GLP-1 buyers. Browse all Peptides & GLP-1 education

This review is independent and editorial. PlexusDx maintains no commercial relationship with Ro, its parent company, or Fridays, and no affiliate links or paid placements appear here.

Full head-to-head: PlexusDx vs Fridays →

Ro and Fridays represent a familiar trade-off in telehealth: scale versus specialization. Ro is a large, multi-condition platform with a long operating history; Fridays is a smaller program built around weight. Neither shape is inherently better — they simply serve different priorities. This comparison reflects the landscape as of April 2026.

Scale versus specialization

The defining contrast is breadth against depth. Roman Health (Ro) operates across many conditions with an established infrastructure and brand recognition, while Fridays Health concentrates its attention on metabolic care. A large platform can offer reach and polish; a focused program can offer a narrower, more tailored experience. Which matters more depends on what you are looking for.

Ro's established telehealth machine

Ro runs as subscription telehealth: a virtual clinical evaluation, a provider-issued prescription, and fulfillment through either FDA-approved brand GLP-1 products or compounded semaglutide and tirzepatide via a licensed pharmacy pathway. As a large operator, its program details and menu evolve, so confirm the current terms on Ro's official website.

Fridays' focused weight program

Fridays pairs telehealth with a compounded-pharmacy pathway and keeps its scope on weight care, with coaching and dietitian support bundled in. Because a smaller program can adjust its offering quickly, verify the live structure and eligibility on Fridays's official website before comparing.

Comparing the money side

Fridays states its rates plainly: compounded semaglutide at $249/mo and compounded tirzepatide at $359/mo month-to-month (joinfridays.com/pricing, verified 2026-07-20), with no membership fee, free shipping, and coaching plus dietitian support included; a prepaid annual plan brings the effective cost to roughly $150/mo and $240/mo. Fridays' rates moved materially within a single day, so verify first. Ro publishes its own pricing separately, and a large platform's tiers can differ by product and program. For reference, PlexusDx month-to-month runs about $60–$70/mo below Fridays on both compounds, while Fridays' prepaid 3- and 6-month bundles undercut PlexusDx per month.

The trial record behind the compounds

Scale does not change the science. GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide were studied in STEP (semaglutide, weight management, NEJM 2021), SURMOUNT (tirzepatide, weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide, obstructive sleep apnea, NEJM 2024). A large platform and a focused program prescribe from the same evidence base; the compound and dose drive the outcome.

The DNA layer neither service reads

Whether care comes from a big platform or a boutique program, the inherited biology goes unmeasured. Variants in FTO (associated with fat mass and obesity), GLP1R (the gene for the GLP-1 receptor every compound targets), MC4R (a melanocortin receptor governing satiety), and TCF7L2 (tied to glucose regulation) sketch the metabolic terrain a clinician prescribes into. These pathway-level markers do not predict compound response but do describe your biology. PlexusDx closes that gap: the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights spanning FTO, MC4R, and TCF7L2, alongside its Weight Management Protocols — Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Reading your baseline before you invest reframes the decision with your provider.

No affiliation: PlexusDx is independent of Ro and has no commercial relationship with any company examined here.

More from the PlexusDx Education Hub: GLP 1 Drugs, GLP 1 Hormone, What Is GLP 1, GLP 1 What Is.

Editorial disclaimer: this comparison is educational, not a buying recommendation. PlexusDx is not affiliated with Ro and sells semaglutide and tirzepatide through its own Weight Management Protocols. The Precision Peptide Genetic Test analyzes how genes influence peptide-related pathways and does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Compare a focused path with genetics built in: see the Weight Management Protocols, or start with the Precision Peptide Genetic Test to read your GLP-1 pathway first.

Frequently Asked Questions

Is a big platform like Ro safer than a smaller program like Fridays?

Size alone does not equal safety. Both a large platform and a focused program should use licensed clinicians, licensed pharmacy partners, and clinical evaluation before prescribing. Scale can mean more infrastructure; specialization can mean more tailored attention. Verify credentialing and licensure on each brand's own site regardless of size.

Does Ro or Fridays offer more medication choice?

A larger platform may list a broader catalog across conditions, while a focused weight program concentrates on GLP-1 options. More choice is not automatically better; what matters is whether the specific compound and format you need are available, at a price and cadence that fit. Check each brand directly.

Does the Precision Peptide Genetic Test work with either program?

The test is independent of any telehealth service and does not predict response to a compound or program. It reads pathway-level variants in FTO and MC4R, and TCF7L2 that describe baseline GLP-1 biology — context you could bring to a provider whether you use a large platform or a focused program.

What sets the PlexusDx approach apart from Ro and Fridays?

PlexusDx offers its own semaglutide and tirzepatide protocols paired with the Precision Peptide Genetic Test. The differentiator is pathway-level genetic context on FTO, MC4R variants — an upstream layer that neither Ro's broad platform nor Fridays' focused program places beside the medication.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.